PresbiDrops (CSF-1)

CSF-1 · Orasis Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PresbiDrops (CSF-1), covering 2017-08-01 to 2017-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of PresbiDrops (CSF-1), a Topical Ophthalmic Drug for Presbyopia [Phase 2]